AKT1 and glioblastoma: The PI3K/AKT pathway is activated by Receptor Tyrosine Kinases (RTK), e.g., EGFR, frequently amplified and upregulated or mutated to produce a constitutive active variant GFRvIII present in approximately 30% of GBM.